← FDA Drug Approvals (Drugs@FDA)

XPHOZAH

NDA · New Drug Application · Sponsor: ARDELYX INC · Approved 2023-10-17

Drug application

FDA Application #

NDA213931

Application type

New Drug Application

Brand name

XPHOZAH

Generic name

TENAPANOR

Active ingredients

TENAPANOR HYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ARDELYX INC

Manufacturer

Ardelyx, Inc.

First approval

2023-10-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown